Stay updated with breaking news from Suraksha Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Leading vaccine maker, Bharat Biotech International Limited (BBIL) on Monday announced that world's first intranasal vaccine for Covid-19, iNCOVACC (BBV154), has received approval from the Central Drugs Standard Control Organisation (CDSCO) ...
Get latest articles and stories on India at LatestLY. iNCOVACC, on Tuesday, became the world's first intra-nasal vaccine to receive both Primary series and Heterologous booster approval, Bharat Biotech International Limited (BBIL) announced India News | India-made INCOVACC, World's First Intra-nasal Vaccine to Receive Approval for Both Primary Series, Heterologous Booster.
INCOVACC, on Tuesday, became the world's first intra-nasal vaccine to receive both Primary series and Heterologous booster approval, Bharat Biotech International Limited (BBIL) announced in a press release.
INCOVACC: Bharat Biotech said that launch dates, pricing and availability will be announced in due course of time.